TORONTO: Nichi-Iko Pharmaceutical Co agreed to buy Sagent Pharmaceuticals Inc for US$736mil in cash, allowing the Japanese company to build its presence in the US market as it looks to become one of the world's top manufacturers of generic medicines.
Nichi-Ikowill pay US$21.75 per share, a premium of about 40% to Sagent's July 8 closing price, the companies said in a statement yesterday.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
